Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnerships
Biotech
Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study
Opko and Entera have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.
James Waldron
Mar 17, 2025 10:10am
BMS' MyoKardia scraps heart muscle pact with Fulcrum
Mar 5, 2025 5:30am
OS Therapies sets up subsidiary to seek ADC joint ventures
Feb 24, 2025 9:30am
Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
Nov 15, 2024 8:30am
Israeli AI firm turns to Google Cloud for small molecule model
Nov 1, 2024 1:47pm
Clario and PathAI partner up to build GI clinical trial workflow
Oct 16, 2024 3:00pm
